Ozempic & Wegovy: Double Power for Health 👊

Name: Ozempic & Wegovy: Double Power for Health 👊
Uploaded: 2024-01-30T16:00:16+00:00
Duration: 49 s
Channel: Dr. Charles Mok
Description: This content was created by Dr. Charles Mok. This content was uploaded by Dr. Charles Mok. This is a YouTube video titled "Ozempic & Wegovy: Double Power…

30 Jan 2024 · 1 min

Watch on YouTube

0:49

This content was created by Dr. Charles Mok. This content was uploaded by Dr. Charles Mok. This is a YouTube video titled "Ozempic & Wegovy: Double Power for Health 👊" (created 2024-01-30). It is an educational health-focused monologue explaining the difference between Ozempic (semaglutide for type 2 diabetes) and Wegovy (for weight loss), describing both as GLP-1 agonists. The speaker outlines the mechanism (GLP-1 activation affecting the brain, pancreas, and gastrointestinal tract), clinical effects (improved insulin sensitivity, decreased cravings for junk food, reduced compulsive behaviors and drinking), and mentions possible benefits for autoimmune diseases.

Chapters

Ozempic is a diabetes formula, and Wegovy is the weight loss formula. Both have been approved FDA approved in the United States. Wegovy for weight loss and certain circumstances, and Semaglutide as ozempic for type 2 diabetes. And they're called GLP1 agonists. Glucagon, like peptide 1 agonist, which means they turn on this GLP1. It was discovered almost a decade ago as part of the pathway that a drug called metformin activates. Metformin raises GLP1 levels up, and this semaglutide pushes GLP1 forward, which has effects in the brain and the pancreas and the gastrointestinal tract. So we respond better with insulin sensitivity. And it decreases cravings for food, especially junk food. Interesting. It decreases cravings and habits, less drinking, less compulsive behaviors. It also has other effects like it seems to help autoimmune diseases.